We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$116M
AUM Growth
-$4.58M
Cap. Flow
-$8.42M
Cap. Flow %
-7.23%
Top 10 Hldgs %
96.58%
Holding
17
New
Increased
Reduced
Closed
3

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARVN icon
1
Arvinas
ARVN
$524M
$32M 27.49%
1,289,521
RLYB icon
2
Rallybio
RLYB
$86.8M
$18.7M 16.05%
412,700
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$17.3M 14.83%
371,693
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$17M 14.63%
1,209,571
EWTX icon
5
Edgewise Therapeutics
EWTX
$4.35B
$12M 10.34%
1,553,661
COGT icon
6
Cogent Biosciences
COGT
$6.75B
$5.94M 5.1%
501,530
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$8.87B
$2.54M 2.18%
141,000
RCKT icon
8
Rocket Pharmaceuticals
RCKT
$353M
$2.35M 2.02%
118,242
PASG icon
9
Passage Bio
PASG
$15.7M
$2.35M 2.02%
124,896
HARP
10
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.24M 1.92%
315,670
ALEC icon
11
Alector
ALEC
$167M
$2.04M 1.75%
339,569
ARAV
12
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.19M 1.02%
946,423
XFOR icon
13
X4 Pharmaceuticals
XFOR
$364M
$650K 0.56%
11,167
ITRM
14
DELISTED
Iterum Therapeutics
ITRM
$104K 0.09%
97,084
TECX
15
Tectonic Therapeutic
TECX
$577M
-26,296
Closed -$316K
CMRX
16
DELISTED
Chimerix, Inc.
CMRX
-1,224,600
Closed -$1.54M
AMYT
17
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-449,737
Closed -$6.56M

Similar funds

New Leaf Venture Partners's Q2 2023 Portfolio in Review

As of Q2 2023, New Leaf Venture Partners held 17 positions worth $116M, down 3.8% from $121M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

New Leaf Venture Partners withdrew a net $8.42M in Q2 2023, closing 3 positions. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners fully exited Amryt Pharma plc American Depositary Shares in Q2 2023, selling an estimated $6.56M.
  • New Leaf Venture Partners's ten largest holdings make up 97% of its $116M portfolio in Q2 2023.
  • New Leaf Venture Partners opened 0 new positions and closed 3 in Q2 2023.
  • New Leaf Venture Partners's portfolio value fell 3.8% quarter-over-quarter to $116M.

Based on New Leaf Venture Partners's 13F filing for Q2 2023, filed 10 Aug 2023.